Francisco Ibarra, PharmD, BCCCP
Adjunct Assistant Professor
Degrees, Education & Certifications:
PharmD, University of California, San Francisco
BA, Psychology (Minor in Education and Applied Psychology), University of California, Santa Barbara
PGY2 Critical Care Pharmacy Residency, The Johns Hopkins Hospital
PGY1 Pharmacy Residency, Stanford Health Care
Board Certified Critical Care Pharmacist
Advanced Cardiovascular Life Support
Basic Life Support
Pediatric Advanced Life Support
Emergency Medicine, Critical Care, Pharmacology
Most Recent Industry Experience:
Emergency Medicine Clinical Pharmacist, Community Regional Medical Center, Fresno, CA
Professional Affiliations & Service:
Member, California Society of Health-System Pharmacists
Member, American Society of Health-System Pharmacists
Latest Research, Publications, and Presentations:
Ibarra, F., Jr, Loi, K., & Vu, A. W. (2022). Safety and Efficacy of Various Intravenous Insulin Infusion Rates in Patients With and Without Diabetes Presenting With Hypertriglyceridemia. The Annals of pharmacotherapy, 10600280211070102. Advance online publication. https://doi.org/10.1177/10600280211070102.
Xiao, S. Q., Ibarra, F., Jr, & Cruz, M. (2021). Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation. The Annals of pharmacotherapy, 10600280211056356. Advance online publication. https://doi.org/10.1177/10600280211056356.
Ibarra F., Jr (2021). Review of Prothrombin Complex Concentrates Use in Apixaban and Rivaroxaban Associated Intracranial Hemorrhages. Journal of pharmacy practice, 8971900211015059. Advance online publication. https://doi.org/10.1177/08971900211015059.